Filing Flows › Cocrystal Pharma (COCP) › Stock forecast & fair value
Cocrystal Pharma (COCP) stock forecast and price target
Cocrystal Pharma (COCP) trades at $1.04. 3 analysts' median price target is $8.00 (+669%), from $6.00 to $10.00.
Cocrystal Pharma's latest quarter
Cocrystal Pharma, Q2 2026: revenue $105K, net loss $3.2M, operating cash flow −$2.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for COCP stock?
The median of 3 analysts' 12-month targets is $8.00, +669% from $1.04; the range is $6.00 to $10.00. The average rating is none.
Does Cocrystal Pharma usually beat earnings estimates?
It beat the consensus EPS estimate in 50% of the quarters on record.
Is COCP stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.